Human Immune Responses Toward HIV-1 Envelope Antigens

Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers

NCT00027482 ·Status: COMPLETED

Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults

NCT00187148 ·Status: COMPLETED ·Phase: PHASE1

Safety, PK and Antiviral Activity of PGT121 Monoclonal Antibody in HIV-uninfected and HIV-infected Adults

NCT02960581 ·Status: COMPLETED ·Phase: PHASE1

Effect of N-803 on B Cell Follicles in Antiretroviral Treated HIV Disease

NCT04808908 ·Status: COMPLETED ·Phase: PHASE1

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

NCT00002172 ·Status: COMPLETED ·Phase: NA

Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3

NCT00000756 ·Status: COMPLETED ·Phase: PHASE1

N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV

NCT04144335 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

NCT00074997 ·Status: COMPLETED ·Phase: PHASE2

Analysis of Immune Responses to HIV Vaccines

NCT00068978 ·Status: COMPLETED

Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection

NCT00856154 ·Status: COMPLETED ·Phase: PHASE1

HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals

NCT03485963 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection

NCT00059462 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients

NCT00000824 ·Status: TERMINATED ·Phase: NA

Examination of B Cell Responses in Human Blood

NCT00806845 ·Status: COMPLETED

Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment

NCT03940521 ·Status: ACTIVE_NOT_RECRUITING

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

NCT00002359 ·Status: COMPLETED ·Phase: PHASE3

An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients

NCT00189930 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

NCT04340596 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

T-cell Responses to Concurrent HIV and Herpesvirus Infections

NCT03996018 ·Status: COMPLETED

Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy

NCT00559416 ·Status: TERMINATED ·Phase: PHASE1

Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452

NCT00006495 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

NCT00005001 ·Status: COMPLETED ·Phase: PHASE2

Adoptive Transfer of Haploidentical NK Cells and N-803

NCT03899480 ·Status: COMPLETED ·Phase: PHASE1

REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study

NCT02291809 ·Status: UNKNOWN ·Phase: PHASE2

A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3

NCT00001064 ·Status: TERMINATED ·Phase: NA